Our article on crypto drug candidate out in Nature today

Very happy to see a terrific collaboration with NITD and Washington State published today. The paper describes new transgenic models to evaluate treatments for cryptosporidiosis and the discovery of Kdu731 a potent PI4K inhibitor. Better treatments for children suffering from diarrhea are urgently needed and we hope that this study will represent a breakthrough towards that goal. We thank NIH and Wellcome Trust for financial support of the work.

Read the paper, and press releases at UGA and Wellcome Trust.